Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

4D Molecular Therapeutics, Inc. - Common Stock (NQ:FDMT)

10.14 +0.18 (+1.81%)
Streaming Delayed Price Updated: 2:16 PM EDT, Oct 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 496,469
Open 10.17
Bid (Size) 10.12 (1)
Ask (Size) 10.16 (2)
Prev. Close 9.960
Today's Range 10.09 - 10.73
52wk Range 2.235 - 10.26
Shares Outstanding 42,052,980
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
4DMT to Participate in Chardan's 9th Annual Genetic Medicines Conference
From 4D Molecular Therapeutics, Inc.
Via GlobeNewswire
4DMT Advances 4D-710 to Phase 2 with Additional Funding and Support from the Cystic Fibrosis Foundation
From 4D Molecular Therapeutics, Inc.
Via GlobeNewswire

Performance

YTD
+73.9%
+73.9%
1 Month
+49.1%
+49.1%
3 Month
+138.0%
+138.0%
6 Month
+248.5%
+248.5%
1 Year
+14.1%
+14.1%

More News

Read More
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
4DMT Announces New Employment Inducement Grants
From 4D Molecular Therapeutics, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Jim Cramer: AppLovin Calls For Prudence, This Health Care Stock Is 'Pure Spec'
Via Benzinga
4DMT Announces Leadership Expansion with Proven Late-Stage Executives to Drive 4D-150 Execution and BLA Readiness
From 4D Molecular Therapeutics, Inc.
Via GlobeNewswire
4DMT to Participate in Upcoming Investor Conferences
From 4D Molecular Therapeutics, Inc.
Via GlobeNewswire
4DMT Announces New Employment Inducement Grants
From 4D Molecular Therapeutics, Inc.
Via GlobeNewswire
What 4 Analyst Ratings Have To Say About 4D Molecular Therapeutics
Via Benzinga
4dMT Revenue Jumps 200 Percent in Q2
Via The Motley Fool
Topics Intellectual Property
4DMT Reports Second Quarter 2025 Financial Results, Operational Highlights and Expected Upcoming Milestones
From 4D Molecular Therapeutics, Inc.
Via GlobeNewswire
4DMT to Participate in the H.C. Wainwright 5th Annual Ophthalmology Virtual Conference
From 4D Molecular Therapeutics, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Unusual volume stocks in Monday's session
Via Chartmill
Assessing 4D Molecular Therapeutics: Insights From 5 Financial Analysts
Via Benzinga
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session.
Via Chartmill
The market is filled with gapping stocks in Friday's session.
Via Chartmill
4D Molecular Therapeutics Rallies On Heels Of Diabetes-Related Vision Study
Via Benzinga
These stocks that are showing activity before the opening bell on Friday.
Via Chartmill
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Why Apple Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
These stocks are moving in today's after hours session
Via Chartmill
4DMT Presents Positive 60-Week Results from 4D-150 SPECTRA Clinical Trial in DME and Regulatory Update
From 4D Molecular Therapeutics, Inc.
Via GlobeNewswire

Frequently Asked Questions

Is 4D Molecular Therapeutics, Inc. - Common Stock publicly traded?
Yes, 4D Molecular Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does 4D Molecular Therapeutics, Inc. - Common Stock trade on?
4D Molecular Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for 4D Molecular Therapeutics, Inc. - Common Stock?
The ticker symbol for 4D Molecular Therapeutics, Inc. - Common Stock is FDMT on the Nasdaq Stock Market
What is the current price of 4D Molecular Therapeutics, Inc. - Common Stock?
The current price of 4D Molecular Therapeutics, Inc. - Common Stock is 10.14
When was 4D Molecular Therapeutics, Inc. - Common Stock last traded?
The last trade of 4D Molecular Therapeutics, Inc. - Common Stock was at 10/16/25 02:16 PM ET
What is the market capitalization of 4D Molecular Therapeutics, Inc. - Common Stock?
The market capitalization of 4D Molecular Therapeutics, Inc. - Common Stock is 426.42M
How many shares of 4D Molecular Therapeutics, Inc. - Common Stock are outstanding?
4D Molecular Therapeutics, Inc. - Common Stock has 426M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.